• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30

Total: 8 results found.

1. The new BELOTERO® syringe from Merz Aesthetics® offers improved precision, comfort, and ease of use
(Press Releases)
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of a new syringe for its category-leading hyaluronic acid (HA) brand BELOTERO®. The new syringe is ...
2. In Afghanistan, the WHO and UNICEF will launch a polio vaccination campaign, utilizing the PharmaJet® Tropis® ID delivery system
(Innovations)
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that the WHO prequalified Tropis ID delivery system ...
3. Avenacy announces the launch of five injectable antibiotic products in the U.S. market
(Innovations)
... generated U.S. sales of approximately $175M for the twelve months ended September 30, 2024, representing a meaningful opportunity in the generic injectables market. “The launch of these five antibiotic ...
4. The next evolution of the V-OVS® syringe closure system is introduced by Vetter
(Press Releases)
...  The new closure, V-OVS® next, will further advance a proprietary system with many years of proven market success supporting and differentiating a range of sterile injectables. This latest evolution ...
5. TB Alliance participates in Indonesia's high-level meeting on tuberculosi
(News)
... – including once-daily oral drugs, fixed-dose combinations, and long-acting injectables – TB Alliance is following the science to find the next TB therapies. "Our mission to end TB demands innovation at ...
6. Avenacy Launched Tranexamic Acid Injection, USP in U.S. Market
(Innovations)
... have aimed to quickly deliver safe, effective, quality specialty injectables to hospitals and providers across the U.S., and the launch of Tranexamic Acid injection marks another important step in fulfilling ...
7. Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative 'GLP-1 Obesity Treatment
(Press Releases)
... GLP-1 analogue therapies. It maintains the efficacy of existing injectables and offers the significant benefit of room temperature storage, eliminating the need for a cold storage system. This is a marked ...
8. American Regent introduces FDA-approved Epinephrine Injection
(News)
... Regent, Inc., a Daiichi Sankyo Group company, is a top-10 injectable manufacturer. For over 50 years, American Regent has been developing, manufacturing and supplying quality generic and branded injectables ...